Riskpilot← Back to searchSign inGet full accessRN-läkarverksamhet AB
ABActiveOrg 5592301922Körvelvägen 21Medical specialists activities · NACE 8622Est. 20192 employees
Revenue 2024
SEK 661K
-26% vs 2023
EBITDA margin
76.4%
-23% vs 2023
Equity ratio
82.3%
Financial strength
Net profit 2024
SEK 417K
-20% vs 2023
| Revenue | SEK 661K | -26% |
| EBITDA | SEK 506K | -23% |
| Net profit | SEK 417K | -20% |
| Total assets | SEK 1,7M | +22% |
| Equity | SEK 1,4M | +19% |
| Employees | 2 | — |
Legal name
RN-läkarverksamhet AB
Org number
5592301922
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 december 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bemanningsföretag inom hälso och sjukvård, främst inom läkarverksamhet. Arbete inom kosmetisk sjukvård. Vidare ska bolaget äga och förvalta aktier, fast och lös egendom samt därmed förenlig verksamhet
Address
Körvelvägen 21
Email
riath_91@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 468 | 1 000 | 610 | 898 | 661 |
| Staff expenses | — | — | −92 | −8 | −12 |
| EBITDA | 450 | 555 | 435 | 660 | 506 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 450 | 555 | 435 | 660 | 506 |
| Net financials | — | — | — | — | 21 |
| Profit before tax | 450 | 555 | 435 | 660 | 527 |
| Tax | −96 | −119 | −90 | −136 | −110 |
| Net profit | 354 | 436 | 345 | 524 | 417 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 613 | 1 073 | 1 074 | 1 384 | 1 686 |
| Equity | 404 | 663 | 829 | 1 166 | 1 388 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 209 | 410 | 245 | 218 | 298 |
| Total debt | 209 | 410 | 245 | 218 | 298 |
EBITDA margin
76.4%
This company
15.8%
Market median
+384% vs market
20202024
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
20202024
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20202024
Net profit margin
63.0%
This company
8.1%
Market median
+678% vs market
20202024
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RN-läkarverksamhet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Safinaz Abdelrahman Abdoun | Deputy Board Member | 0 companies |
| Riyath Nassr | Board of Directors | 0 companies |